Ligand Pharmaceuticals, Inc. - Ordinary Shares - Class B
LGND
Market Cap$1.97B
Close$
$76.60
26.5% downside
Current Fair Value
26.5% downsideOvervalued by 26.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.97 Billion |
|---|---|
| Enterprise Value | $1.94 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.22 |
| Beta | 0.76 |
| Outstanding Shares | 19,191,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -14.79 |
|---|---|
| PEG | 9.91 |
| Price to Sales | 11.58 |
| Price to Book Ratio | 2.54 |
| Enterprise Value to Revenue | 10.67 |
| Enterprise Value to EBIT | -54.85 |
| Enterprise Value to Net Income | -15 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ligand Pharmaceuticals, Inc.
CEO: John Higgins